Metrics as of 10/17/2026, 08:39 AM (Berlin time), refresh in progress.
GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program…
1D
-5.4%
1W
-15.1%
1M
+43.5%
6M
+46.0%
YTD
-9.4%
1Y
-13.7%
2Y
+151.2%
5Y
-100.0%
10Y
-100.0%
Next earnings date
16/11/2026 (in 30 days)
Volatility around earnings
~19% stronger price swings than usual
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
No current analyst ratings available.
P/E
-0.98
P/B
1.48
EV/EBITDA
-3.01
RETURN ON EQUITY
-69.9%
NET MARGIN
-14,927.4%
DEBT/EQUITY
0.1
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
85.3%
FLOAT SHARES
6,079,615
AVG. DAILY VOLUME (30D)
93,308
Sawyer Jason David
Sawyer Jason David
Sawyer Jason David
Syage Jack
GridAI Technologies Corp. is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Jason David Sawyer, the company employs around 2 people.
The IPO was on 11/10/2016; the stock trades on NASDAQ under the ticker GRDX.
The next earnings date is 16/11/2026.
Around past earnings, price swings were roughly 19% stronger than usual.
No, GridAI Technologies currently does not pay a dividend.
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
Clicking "Analyze stock" lets five strategies assess GridAI Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.